The aim of the project is to foster the dialogue and development towards more inclusive, dynamic, (gender) diverse and interconnected innovation ecosystems in Europe to reach the European common data space in health. The joint action plan to be developed in the context of the project is oriented at overcoming the current deployment gap of digital health in Europe and to unlock the power of health data for innovative medicine and healthcare of the future, enabling new scientific discoveries, innovative commercial health products and services, all in all resulting in more efficient prevention and treatment of illnesses and ensuring a better quality of life in Europe and globally. The consortium includes four clusters/networks, all representing broad innovation ecosystems, that have for many years been working to advance the secondary use of health data and creation of the common European Health Data Space. This includes Biocat, BioRegion of Catalonia (Biocat; coordinating country: Spain), Council of European BioRegions (CEBR; based in Belgium), Health Cluster Portugal (HCP, Portugal) and ScanBalt network (SB; Estonia). The consortium takes leadership in coordinating the project activities but a wide range of clusters, bioregions and wider ecosystem stakeholders will be engaged in the project based on the joint effort of the core partners.

COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…). COBIOE will reach the following objectives: - Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities - Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain. - Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players. - Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakers COBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing. Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).

The lack of qualified Human Resources is one of the biggest weaknesses of Vietnamese’s Health Care system: there are only 1,2 medical doctors per 1000 inhabitants, while EU average indicator is 3.3 per 1000 inhabitants. The low number of doctors comes from limited capacity of universities to prepare and train medical professionals, the available staff resources are distributed unequally among specialties, geographical areas and levels. To address these problems, the project has two primary aims:• To improve the teaching skills and research infrastructure of Vietnamese HEIs in the field of medicine through pedagogical training and technical assistance • To improve the quality of Vietnamese HEIs and enhance their relevance for the labor market and society in the field of Medicine by establishing a high quality interdisciplinary PhD curriculum in Molecular Medicine Achieving these objectives would increase the capacity of Vietnamese universities so they can provide high quality training of medical doctors and fill an important labor market gap while meeting multiple societal needs such as improved health for citizens. In the long-term, in addition to producing more doctors, the Medical PhD program – the 1st of its kind in Vietnam - would produce skilled researchers to engage in internationally competitive research. The focus on transferable skills for faculty and students will make them more competitive in the labor market. Graduates would also serve as future teachers, thus increasing the number of faculty with PhDs. The training provided to faculties and students will also prepare them to think more entrepreneurialy and be given networking opportunities with the Vietnamese and European healthcare industry. All of this activity will take place in 3 regions that have been targeted as in need of development by the Vietnamese government.